Populære områder

Populære kategorier

Virksomhedsregister

Aakard Compliance

email

customer_icon

Marstein Surgical Consult

Merit Medical Denmark A/S

Niche Pharma v/Carsten R

homepage

Vetinject A/S

Biogen Idec International Gmbh

facebook

Varmx B.V.

Biogen Idec

Acp 30.06.2012 1 A/S

Acp 30.06.2012 3 A/S

Acp 30.06.2012 4 A/S

Novo Nordisk A/S - Th7

Virogates A/S

logo

cover_photo

ViroGates A/S is an international medical technology company developing and marketing blood test products under the suPARnostic® brand for better triaging in hospitals to improve patient care, reduce healthcare costs and empower clinical staff. The products are primarily used at emergency departments in hospitals for risk stratification of acute medical patients to improve clinical decisions on discharge and hospitalization. ViroGates’ suPARnostic® product range measures the protein, suPAR (soluble urokinase Plasminogen Activator Receptor). The protein is naturally occurring in human blood and reflects the immune system’s activation level. A patient’s suPAR level predicts negative outcomes such as short-term mortality across acute and chronic diseases. The suPARnostic® tests are easily integrated into existing hospital workflows and instruments, and the results are available in 10-20 minutes.

free_text

BioPorto Diagnostics A/S

Novo Nordisk Foundation Cellerator P/S

Nvac P/S

Enterotarget ApS

Apotekeren A.m.b.a.

Nordiccell ApS

Zerion Pharma A/S

Mt-Microsearch ApS

Freya Biosciences License ApS

Freya Biosciences ApS

Bavarian Nordic A/S

Aktieselskabet af 1. Juni 2011 I